United StatesHouse Bill 4101HR 4101
Cancer Drug Parity Act of 2025
Health
5 pages
- house
- senate
- president
Last progress June 24, 2025 (5 months ago)
Introduced on June 24, 2025 by Glenn Grothman
Sponsors (25)
House Votes
Pending Committee
June 24, 2025 (5 months ago)Referred to the House Committee on Education and Workforce.
Senate Votes
Vote Data Not Available
Presidential Signature
Signature Data Not Available
AI Summary
This bill would make employer group health plans treat cancer pills the same as chemo given in a clinic when it comes to what patients pay out of pocket. It requires plans to offer cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing for anticancer medicines given by a health care provider.
Key points:
- Who is affected: People enrolled in group health plans (and the plans themselves).
- What changes: Out-of-pocket costs for cancer pills must be no worse than for provider-administered cancer drugs.
- Where it fits: It amends federal rules for employer health plans to ensure this parity.
Text Versions
Text as it was Introduced in House
ViewJune 24, 2025•5 pages
Amendments
No Amendments